Literature DB >> 2374887

Gender differences in affective, schizoaffective, and schizophrenic disorders.

T H McGlashan1, K K Bardenstein.   

Abstract

This study examines gender differences in the clinical profiles and long-term outcomes of chronic DSM-III Axis I psychotic inpatients from the Chestnut Lodge followup study. Diagnostic groups include schizophrenia, schizoaffective psychosis, and unipolar affective disorder. Sex differences were frequent, especially in schizophrenia. Females with schizophrenia, for example, had superior premorbid social, sexual, and marital adjustments. They presented at index hospitalization with more depression, self-destructive behaviors, and troubled interpersonal relationships. Their long-term outcomes were better than males in terms of social activity, work competence, time symptomatic, substance abuse, and marital and parental status. Baseline gender differences were comparatively sparse for the schizoaffective and unipolar cohorts. Outcome differences were virtually nonexistent among the schizoaffective patients but unipolar females received better ratings than males in work competence and substance abuse. Females had a later onset of illness and males presented with more antisocial behaviors across all three diagnostic groups. Results highlight the importance of analyzing data by gender in studies of the psychotic disorders.

Entities:  

Mesh:

Year:  1990        PMID: 2374887     DOI: 10.1093/schbul/16.2.319

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  22 in total

Review 1.  The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings.

Authors:  Marrit K de Boer; Stynke Castelein; Durk Wiersma; Robert A Schoevers; Henderikus Knegtering
Journal:  Schizophr Bull       Date:  2015-02-25       Impact factor: 9.306

2.  When and how does schizophrenia produce social deficits?

Authors:  H Häfner; B Nowotny; W Löffler; W an der Heiden; K Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

3.  Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder.

Authors:  Rafael Segarra; Natalia Ojeda; Arantzazu Zabala; Jon García; Ana Catalán; Jose Ignacio Eguíluz; Miguel Gutiérrez
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-05-26       Impact factor: 5.270

4.  Expenditures of time and money by families of people with severe mental illness and substance use disorders.

Authors:  R E Clark; R E Drake
Journal:  Community Ment Health J       Date:  1994-04

Review 5.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

6.  Gender differences in substance use, consequences, motivation to change, and treatment seeking in people with serious mental illness.

Authors:  Amy Drapalski; Melanie Bennett; Alan Bellack
Journal:  Subst Use Misuse       Date:  2010-12-21       Impact factor: 2.164

7.  Age, gender and quality of life.

Authors:  C Mercier; N Péladeau; R Tempier
Journal:  Community Ment Health J       Date:  1998-10

8.  Lack of Gender-Related Differences in Childhood-Onset Schizophrenia.

Authors:  Anna E Ordóñez; Frances F Loeb; Xueping Zhou; Lorie Shora; Rebecca A Berman; Diane D Broadnax; Peter Gochman; Siyuan Liu; Judith L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-07-01       Impact factor: 8.829

9.  School-associated problem behavior in childhood and adolescence and development of adult schizotypal symptoms: a follow-up of a clinical cohort.

Authors:  Selene Fagel; Leo de Sonneville; Herman van Engeland; Hanna Swaab
Journal:  J Abnorm Child Psychol       Date:  2014

10.  Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.

Authors:  Deborah J Walder; Carrie W Holtzman; Jean Addington; Kristin Cadenhead; Ming Tsuang; Barbara Cornblatt; Tyrone D Cannon; Thomas H McGlashan; Scott W Woods; Diana O Perkins; Larry J Seidman; Robert Heinssen; Elaine F Walker
Journal:  Schizophr Res       Date:  2013-01-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.